Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05488886 · ClinicalTrials.gov registry record · NA
Bioavailability of Aronia Berry Polyphenols
A NA study, sponsored by University of Wisconsin, Madison.
- Completed
- Registry status
- NA
- Development phase
- 13
- Enrollment target
NCT05488886: Completed NA study, sponsored by University of Wisconsin, Madison.
NCT05488886 is a NA study that has completed, run by University of Wisconsin, Madison. The registered enrollment target is 13 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05488886, a NA study, has completed, sponsored by University of Wisconsin, Madison.
- COMPLETED
- Registry status
- NA
- Development phase
- 13 participants
- Enrollment target
Study Summary
The objective of this study is to conduct a randomized cross-over dietary intervention among healthy adults to compare the bioavailability and the fecal polyphenol metabolites of intervention foods made with whole aronia berry powder, aronia berry extract, phospholipid-polyphenol (PLP), and a low-polyphenol control. 10 participants will be enrolled and can expect to be on study for up to 28 days.
Primary Outcome
Targeted analysis of free urinary polyphenol metabolites will be performed by ultra-high performance liquid chromatography tandem mass spectrometry (UHPLC-MS/MS).
Interventions
- DIETARY_SUPPLEMENT Whole Aronia Berry Powder Applesauce
- DIETARY_SUPPLEMENT Aronia Berry Extract Applesauce
- DIETARY_SUPPLEMENT Phospholipid-Polyphenol Applesauce
- OTHER Low-Polyphenol Control Applesauce
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 13 participants |
| Start Date | 2023-02-09 |
| Est. Completion | 2023-03-28 |
| Phase | NA |
What the finished NCT05488886 record still lists
NCT05488886 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 13 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 4 interventions - of which Whole Aronia Berry Powder Applesauce is the first listed.
NCT05488886 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05488886 about?
NCT05488886 is a clinical study titled "Bioavailability of Aronia Berry Polyphenols". The objective of this study is to conduct a randomized cross-over dietary intervention among healthy adults to compare the bioavailability and the fecal polyphenol metabolites of intervention foods made with whole aronia berry powder, aronia berry extract, phospholipid-polyphenol (PLP), and a low-po...
What is the current status of trial NCT05488886?
This trial is currently completed. It is a NA study. The enrollment target is 13 participants. The study started on 2023-02-09. Estimated completion is 2023-03-28.
What interventions are being tested in trial NCT05488886?
The interventions under investigation include: Whole Aronia Berry Powder Applesauce (DIETARY_SUPPLEMENT), Aronia Berry Extract Applesauce (DIETARY_SUPPLEMENT), Phospholipid-Polyphenol Applesauce (DIETARY_SUPPLEMENT), Low-Polyphenol Control Applesauce (OTHER).
Who is sponsoring clinical trial NCT05488886?
This trial is sponsored by University of Wisconsin, Madison, which has 1,039 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05488886's enrollment target sits among peer trials
13 1911th of 2000 higher than 88 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03125655 · 13 participants
Regulation of Inflammatory Genes in Psoriasis
- NCT03774446 · 13 participants · Phase 2
Multicenter Study of Seliciclib (R-roscovitine) for Cushing Disease
- NCT03830151 · 13 participants · Phase 1
Hyperpolarized Carbon C 13 Pyruvate in Diagnosing Glioma in Patients With Brain Tumors
- NCT04573231 · 13 participants · Phase 2
Evaluation of PSMA in HER2- AR+ Metastatic Breast Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI